Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

New 5-HT2C agonist and its use in erectile dysfunction discussed at ACS meeting

Aug. 23, 2002

Potassium channel openers for use in bladder overactivity presented by Abbott at ACS

Aug. 22, 2002

Pivotal Alprox-TD studies complete enrollment

Aug. 21, 2002

SAR on novel PDE5 inhibitors reported by Pfizer

Aug. 19, 2002

New vasopressin V1a/V2 modulators for renal failure and hypertension

Aug. 7, 2002

AVI-4126 completes phase Ib polycystic kidney disease trial

Aug. 7, 2002

Swedish approval for dutasteride for benign prostatic hyperplasia

July 30, 2002

CPMP hands down positive opinion for Cialis

July 29, 2002

Approvable letter received for vardenafil

July 25, 2002

Vasopressin antagonists identified at Yamanouchi

July 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...